Veracyte, Inc (NASDAQ:VCYT) Director Muna Bhanji Sells 1,539 Shares modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eighteen ratings firms that are presently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation and fifteen have assigned a buy recommendation to the company. The average 1-year price […]
Veracyte, Inc (NASDAQ:VCYT) Receives $30 60 Consensus Price Target from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Clough Capital Partners L P boosted its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 7.3% in the first quarter, Holdings Channel reports. The firm owned 339,978 shares of the biotechnology company’s stock after purchasing an additional 23,002 shares during the period. Clough Capital Partners L P’s holdings in Veracyte were worth […]
Atom Investors LP purchased a new position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 44,583 shares of the biotechnology company’s stock, valued at approximately $994,000. Atom Investors LP owned about 0.06% of […]